Amanta Healthcare Limited
Promoter holding in Amanta Healthcare Limited was 63.80% in Jun 2026, up 0.08 points from the previous quarter. Since Jun 2025 it has risen 0.24 points.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Jun '26 | 63.80%▲0.08 | 36.20%▼0.08 |
| Mar '26 | 63.72%▲0.16 | 36.28%▼0.16 |
| Dec '25 | 63.56%=0.00 | 36.44%=0.00 |
| Sep '25 | 63.56%=0.00 | 36.44%=0.00 |
| Jun '25 | 63.56% | 36.44% |
Trend
- Of the last 4 quarterly changes on record, promoter holding rose in 2 and stayed the same in 2.
- The largest quarterly change was a rise of 0.16 points in the quarter to Mar 2026.
Compared with similar companies
Promoter holding in Amanta Healthcare Limited is higher than 68% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Amanta Healthcare Limited | 63.80% |
| Wanbury Limited | 43.02% |
| Gaudium IVF and Women Health Limited | 71.29% |
| Kilitch Drugs (India) Limited | 63.77% |
| One Global Service Provider Limited | 68.40% |
| Fabtech Technologies Limited | 68.94% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Amanta Healthcare Limited's promoter holding?
Promoters held 63.80% of Amanta Healthcare Limited as of 30 Jun 2026, and the public held 36.20%.
Has Amanta Healthcare Limited's promoter holding increased?
Yes, it rose by 0.08 percentage points in the quarter to Jun 2026.
Are any promoter shares of Amanta Healthcare Limited pledged?
No promoter shares are recorded as pledged.
How does Amanta Healthcare Limited's promoter holding compare with similar companies?
Promoter holding in Amanta Healthcare Limited is higher than 68% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.